IRRAS Announces Key IRRAflow Commercial Milestones in Germany
Stockholm, October 22, 2020 – IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced important commercial milestones from the launch of its IRRAflow system in Germany. The company generated its initial revenue in Germany and also completed the first German patient since launching the most recent version of IRRAflow.Initial Evaluation Agreement Signed, First Revenue Generated The latest generation of IRRAflow was launched in Europe in the first quarter of this year after securing the product’s